Yao M - Search Results

1

Reduced red blood cell count predicts poor survival after surgery in patients with primary liver cancer.

Xie X, Yao M, Chen X, Lu W, Lv Q, Wang K, Zhang L, Lu F. Xie X, et al. Among authors: yao m. Medicine (Baltimore). 2015 Feb;94(8):e577. doi: 10.1097/MD.0000000000000577. Medicine (Baltimore). 2015. PMID: 25715259 Free PMC article.

2

Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.

Zeng Z, Tu J, Cheng J, Yao M, Wu Y, Huang X, Xie X, Zhang X, Lu F, Chen X. Zeng Z, et al. Among authors: yao m. Tumour Biol. 2015 Sep;36(9):6891-900. doi: 10.1007/s13277-015-3401-7. Epub 2015 Apr 8. Tumour Biol. 2015. PMID: 25851350 Free PMC article.

3

Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.

Zhang J, Cheng J, Zeng Z, Wang Y, Li X, Xie Q, Jia J, Yan Y, Guo Z, Gao J, Yao M, Chen X, Lu F. Zhang J, et al. Among authors: yao m. Oncotarget. 2015 Dec 8;6(39):42040-52. doi: 10.18632/oncotarget.5969. Oncotarget. 2015. PMID: 26547929 Free PMC article.

4

Preoperative Nutritional Risk Index to predict postoperative survival time in primary liver cancer patients.

Bo Y, Yao M, Zhang L, Bekalo W, Lu W, Lu Q. Bo Y, et al. Among authors: yao m. Asia Pac J Clin Nutr. 2015;24(4):591-7. doi: 10.6133/apjcn.2015.24.4.26. Asia Pac J Clin Nutr. 2015. PMID: 26693742 Free article.

5

Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.

Yao M, Zhao J, Lu F. Yao M, et al. Oncotarget. 2016 Jan 26;7(4):3702-8. doi: 10.18632/oncotarget.6913. Oncotarget. 2016. PMID: 26784252 Free PMC article.

6

[Correlation between red blood cell count and liver function status].

Xie X, Wang L, Yao M, Wen X, Chen X, You H, Jia J, Zhao J, Lu F. Xie X, et al. Among authors: yao m. Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):119-22. doi: 10.3760/cma.j.issn.1007-3418.2016.02.009. Zhonghua Gan Zang Bing Za Zhi. 2016. PMID: 26983479 Chinese.

7

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.

Liu T, Yao M, Liu S, Wang L, Wang L, Hou J, Ma X, Jia J, Zhao J, Zhuang H, Lu F. Liu T, et al. Among authors: yao m. Oncotarget. 2017 Mar 7;8(10):16498-16506. doi: 10.18632/oncotarget.14954. Oncotarget. 2017. PMID: 28157705 Free PMC article.

8

The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.

Yao M, Wang L, Leung PSC, Li Y, Liu S, Wang L, Guo X, Zhou G, Yan Y, Guan G, Chen X, Bowlus CL, Liu T, Jia J, Gershwin ME, Ma X, Zhao J, Lu F. Yao M, et al. Clin Rev Allergy Immunol. 2018 Apr;54(2):282-294. doi: 10.1007/s12016-017-8655-y. Clin Rev Allergy Immunol. 2018. PMID: 29256057 Review.

9

Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.

Zhang T, Guan G, Chen T, Jin J, Zhang L, Yao M, Qi X, Zou J, Chen J, Lu F, Chen X. Zhang T, et al. Among authors: yao m. Asia Pac J Clin Oncol. 2018 Oct;14(5):e352-e358. doi: 10.1111/ajco.12982. Epub 2018 May 11. Asia Pac J Clin Oncol. 2018. PMID: 29749051

10

Diacylglycerol kinase γ predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.

Guo Z, Jia J, Yao M, Kang J, Wang Y, Yan X, Zhang L, Lv Q, Chen X, Lu F. Guo Z, et al. Among authors: yao m. Exp Cell Res. 2018 Dec 15;373(1-2):211-220. doi: 10.1016/j.yexcr.2018.11.001. Epub 2018 Nov 3. Exp Cell Res. 2018. PMID: 30399372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,492 results

Search Page

Filters